Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | SLC9A1 | P19634 | 6/20 | 0.56 |
| ▸ | CYP4Z1 | Q86W10 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SI | P14410 | 1/20 | 0.47 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10433633 | 0.98 | SLC9A1 (0.57) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL9191029 | 0.98 | SLC9A1 (0.57) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL9483599 | 0.98 | SLC9A1 (0.57) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL4080308 | 0.95 | TSHR (0.59) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL9483441 | 0.89 | TSHR (0.63) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL22498386 | 0.83 | TSHR (0.59) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL17103020 | 0.83 | TSHR (0.59) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL17664884 | 0.82 | TSHR (0.52) | TSHRNPSR1RXFP1SLC9A1KMT2A | |
| SCHEMBL4006352 | 0.82 | TSHR (0.67) | TSHRNPSR1RXFP1SLC9A1CYP4Z1 | |
| SCHEMBL17664885 | 0.81 | TSHR (0.54) | TSHRNPSR1RXFP1SLC9A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0397450-B1 | NOVEL COPPER AND COPPER ALLOY CORROSION INHIBITORS | CALGON CORPORATION (US) | 1993-01-07 | — | — | EP | claimed |
| EP-0397450-A1 | Novel copper and copper alloy corrosion inhibitors | CALGON CORPORATION (US) | 1990-11-14 | — | — | EP | claimed |
| CN-122055487-A | Non-phosphate corrosion inhibiting compositions and methods for reducing corrosion in cooling water applications | 埃科莱布美国股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20150202292-A1 | ELECTROCHEMICALLY DEGRADABLE POLYMERS | TRUSTEES OF TUFTS COLLEGE D B A TUFTS UNIVERSITY (US) | 2015-07-23 | — | — | US | disclosed |
| EP-2788369-A1 | PREPARATION AND USE OF ISOLACTOSAMINE AND INTERMEDIATES THEREFOR | Glycom A/S (DK) | 2014-10-15 | — | — | EP | disclosed |
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GLYCOM A/S (DK) | 2014-10-09 | — | — | US | disclosed |
| US-8834901-B2 | Electrochemically degradable polymers | TRUSTEES OF TUFTS COLLEGE (US) | 2014-09-16 | — | — | US | disclosed |
| WO-2013083136-A1 | PREPARATION AND USE OF ISOLACTOSAMINE AND INTERMEDIATES THEREFOR | GLYCOM A/S (DK) | 2013-06-13 | — | — | WO | disclosed |
| US-20090024074-A1 | Electrochemically degradable polymers | TRUSTEES OF TUFTS COLLEGE D/B/A TUFTS UNIVERSITY | 2009-01-22 | — | — | US | disclosed |
| EP-1812480-A2 | ELECTROCHEMICALLY DEGRADABLE POLYMERS | TRUSTEES OF TUFTS COLLEGE (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006044795-A2 | ELECTROCHEMICALLY DEGRADABLE POLYMERS | TRUSTEES OF TUFTS COLLEGE (US) | 2006-04-27 | — | — | WO | disclosed |
| EP-0478247-B1 | Alkoxybenzotriazole compositions and the use thereof as copper and copper alloy corrosion inhibitors | CALGON CORP (US) | 1995-12-27 | — | — | EP | disclosed |
| US-5236626-A | For aqueous systems | CALGON CORPORATION (US) | 1993-08-17 | — | — | US | disclosed |
| US-5217686-A | Mixture with other triazole compounds | CALGON CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0397450-B1 | NOVEL COPPER AND COPPER ALLOY CORROSION INHIBITORS | CALGON CORPORATION (US) | 1993-01-07 | — | — | EP | disclosed |
| EP-0478247-A2 | Alkoxybenzotriazole compositions and the use thereof as copper and copper alloy corrosion inhibitors | Calgon Corporation (US) | 1992-04-01 | — | — | EP | disclosed |
| EP-0397450-A1 | Novel copper and copper alloy corrosion inhibitors | CALGON CORPORATION (US) | 1990-11-14 | — | — | EP | disclosed |
| EP-0397455-A1 | Novel alkoxybenzotriazole compounds | CALGON CORPORATION (US) | 1990-11-14 | — | — | EP | disclosed |
| EP-0015240-A1 | Azacyclyl (thio) ureidoacetyl compounds and their preparation | CIBA-GEIGY AG (CH) | 1980-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090024074-A1 | Electrochemically degradable polymers | NQO1, SQOR, APEX1 | TSHR 4454/4885NPSR1 2778/4885RXFP1 3953/4885 |
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GALE, B4GALT1, GNE | TSHR 4278/4885NPSR1 2881/4885RXFP1 1353/4885 |
| US-20150202292-A1 | ELECTROCHEMICALLY DEGRADABLE POLYMERS | NQO1, SQOR, APEX1 | TSHR 4454/4885NPSR1 2778/4885RXFP1 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.